| Rainer Malik | Harvard Medical School (I.D., Brigham and Women's Hospital, MA University of Bordeaux (M.S., Inserm, Bordeaux Population Health Research Center, France Glenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases (M.S.), University of Texas Health, San Antonio Massachusetts General Hospital (P.G.), Boston Institute for Stroke and Dementia Research (R.M.), Klinikum der Universitat Munchen, Ludwig-Maximilians-University, University of Lille Inserm U1167 (P.A.), Lille Centre Hospitalier Universitaire Lille (P.A.) Institut Pasteur de Lille (P.A.), Helsinki University Central Hospital, Neurology Clinic, Brescia University Hospital, Italy Institute of Public Health (T.K.), Charite-Universitatsmedizin Berlin, CHU de Bordeaux |
| Philippe Amouyel | Harvard Medical School (I.D., Brigham and Women's Hospital, MA University of Bordeaux (M.S., Inserm, Bordeaux Population Health Research Center, France Glenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases (M.S.), University of Texas Health, San Antonio Massachusetts General Hospital (P.G.), Boston Institute for Stroke and Dementia Research (R.M.), Klinikum der Universitat Munchen, Ludwig-Maximilians-University, University of Lille Inserm U1167 (P.A.), Lille Centre Hospitalier Universitaire Lille (P.A.) Institut Pasteur de Lille (P.A.), Helsinki University Central Hospital, Neurology Clinic, Brescia University Hospital, Italy Institute of Public Health (T.K.), Charite-Universitatsmedizin Berlin, CHU de Bordeaux |
| Daniel I Chasman | Harvard Medical School (I.D., Brigham and Women's Hospital, MA University of Bordeaux (M.S., Inserm, Bordeaux Population Health Research Center, France Glenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases (M.S.), University of Texas Health, San Antonio Massachusetts General Hospital (P.G.), Boston Institute for Stroke and Dementia Research (R.M.), Klinikum der Universitat Munchen, Ludwig-Maximilians-University, University of Lille Inserm U1167 (P.A.), Lille Centre Hospitalier Universitaire Lille (P.A.) Institut Pasteur de Lille (P.A.), Helsinki University Central Hospital, Neurology Clinic, Brescia University Hospital, Italy Institute of Public Health (T.K.), Charite-Universitatsmedizin Berlin, CHU de Bordeaux |
| Daniel I Chasman | Harvard Medical School (I.D., Brigham and Women's Hospital, MA University of Bordeaux (M.S., Inserm, Bordeaux Population Health Research Center, France Glenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases (M.S.), University of Texas Health, San Antonio Massachusetts General Hospital (P.G.), Boston Institute for Stroke and Dementia Research (R.M.), Klinikum der Universitat Munchen, Ludwig-Maximilians-University, University of Lille Inserm U1167 (P.A.), Lille Centre Hospitalier Universitaire Lille (P.A.) Institut Pasteur de Lille (P.A.), Helsinki University Central Hospital, Neurology Clinic, Brescia University Hospital, Italy Institute of Public Health (T.K.), Charite-Universitatsmedizin Berlin, CHU de Bordeaux |